Publications by authors named "R Goldszer"
Article Synopsis
- Bamlanivimab and casirivimab/imdevimab are monoclonal antibody treatments that lower COVID-19 viral load and might prevent hospitalizations, but limited data exists comparing their effectiveness.
- A study involving emergency department patients with COVID-19 assessed the efficacy and safety of these treatments by monitoring hospitalizations, symptom improvement, and adverse reactions over 30 days.
- Results showed no significant differences in hospitalization rates or other outcomes between the two treatments, with few adverse events reported.
Introduction: The discharge conversation is a critical component of the emergency department encounter. Studies suggest that emergency medicine (EM) residency education is deficient in formally training residents on the patient discharge conversation. Our goal was to assess the proficiency of EM residents in addressing essential elements of a comprehensive discharge conversation; identify which components of the discharge conversation are omitted; introduce "DC HOME," a standardized discharge mnemonic; and determine whether its implementation improved resident performance and patient satisfaction.
View Article and Find Full Text PDF